A systematic review was conducted to investigate the relationship between visual impairment and depression in the elderly. We searched electronic databases (LILACS, SciELO, MEDLINE, and Cochrane Central Register of Controlled Trials) from inception to August 2014 and researched the described references. The search strategy used the following terms: (visual impairment or blindness) and (elderly) and (depression). Of the 641 electronics, 42 works were selected in full and another 20 were identified as being possibly relevant. Ten studies were included. The studies ranged in sample size from 31 to 21,995 participants. Depression was associated with visual impairment in all studies; however, without standardization of diagnostic tests, we could not conduct a meta-analysis or establish a relationship between visual impairment and depression in the elderly.
Hemoglobinopathies are a group of hereditary diseases that cause quantitative or qualitative changes in the shape, function or synthesis of hemoglobin. One of the most common is sickle cell anemia, which, due to sickling of erythrocytes, causes vaso-occlusive phenomena. Among the possible ocular manifestations, the most representative is retinopathy, which can lead to blindness if left untreated. Therefore, periodic ophthalmologic monitoring of these patients is important for early diagnosis and adequate therapeutic management, which can be done localy by treating the lesions in the eyes, or systemically.
Objetivo: Determinar a adesão aos colírios antiglaucomatosos em pacientes do Projeto Glaucoma (Ministério da Saúde) por meio da escala de Morisky de 8 itens. Métodos: Foi realizado um estudo transversal por meio de questionário aplicado a 237 pacientes diagnosticados com glaucoma inscritos regularmente no Projeto Glaucoma do Instituto de Olhos de Maceió, adaptando a escala de Morisky já validada em português para colírios. As variáveis foram a adesão aos colírios antiglaucomatosos, idade, sexo, raça, tempo de diagnóstico do glaucoma, número de colírios utilizados, doenças sistêmicas, escolaridade, perfil de visão (ruim, razoável ou boa) e os fatores correlacionados com a adesão. A análise estatística entre as variáveis foi realizada com os testes estatísticos do Quiquadrado para as variáveis categóricas e Teste U de Mann-Whitney para as contínuas, considerando um nível de significância de 5%. Resultados: A adesão aos colírios foi de 54%. A idade e o número de colírios (p=0,02 e 0,03 respectivamente) foram estatisticamente relevantes, assim como a qualidade de visão também foi (p<0,001) para o não uso adequado do tratamento. O motivo mais comum tanto no grupo de aderentes como no de não aderentes foi o esquecimento (23% e 76,15% respectivamente). Conclusão: Utilizando a escala de Morisky adaptada para colírios antiglaucomatosos a adesão aos colírios foi de 54% .Descritores: Adesão ao tratamento/estatística & dados numéricos; Cooperação do paciente; Recusa do paciente ao tratamento; Soluções oftálmicas/uso terapêutico; Glaucoma/quimioterapia
ABSTRACT
Objective: To determine adherence to glaucoma eye drops in patients from Glaucoma Project (Ministry of Health) by Morisky scale of 8 items. Methods: We conducted a cross-sectional study through a questionnaire applied to 237 patients diagnosed with glaucoma regularly enrolled in the Glaucoma
SUMMARY Coronavirus disease 2019 (COVID-19) caused by the highly pathogenic SARS-Cov-2 virus, was declared as a pandemic by the World Health Organization (WHO) in March 2020. Its main clinical manifestations are related to airway involvement; however, there is extrapulmonary impairment in some cases. Given this context, this literature review aims to identify the ophthalmological conditions caused by infection with the novel coronavirus. Although ocular findings do not include the standard clinical presentation of the disease, there are reports of some ophthalmological changes in COVID-19 patients, and conjunctivitis is the most common among these.
Summary Objective: Determine whether there is an association between the risk of cardiovascular adverse events and the use of antipsychotic agents. Method: Analysis of original articles retrieved from the following databases: LILACS, PubMed, Cochrane Controlled Trials Clinical Data Bank (CENTRAL) and PsycINFO, without language restriction, dated until November 2015. After screening of 2,812 studies, three cohort original articles were selected for quality analysis. Results: 403,083 patients with schizophrenia and 119,015 participants in the control group data were analyzed. The occurrence of cardiovascular events observed in the articles was: 63.5% (article 1), 13.1% (article 2) and 24.95% (article 3) in the group of treated schizophrenic patients, and 46.2%, 86.9% and 24.9%, respectively, in the control groups. Conclusion: Clinical heterogeneity among the studies led to a provisional response and made it impossible to perform the meta-analysis, although the articles demonstrate an association between cardiovascular adverse events and the use of antipsychotics. More quality clinical trials are needed to support this evidence.
Dry eye disease (DED) is a multifactorial disease affecting tear quality and/or production and eye surface and is one of the most common eye disorders found in clinical practice. The association between psychiatric disorders and dry eye has been the subject of several studies since patients with this syndrome present a tendency toward a depressive mood. This narrative review aims to demonstrate the relationship between depression and DED, which is due to the side effects of psychotropic drugs or the tendency of the low pain threshold of the depressive patient. The work was produced from the analysis of 13 articles published during the last decade on this subject and demonstrated that the depressive state is linked to the appearance or worsening of DED resulting from chronic eye pain. Also, the treatment of depression with selective inhibitors of serotonin receptors causes inflammatory cytokine secretion with subsequent inflammation and apoptosis of cells on the ocular surface. The need for new studies on optimization of psychiatric treatment in patients with ophthalmic diseases, such as DED, was verified, aiming at the relief of symptoms and the reduction of psychological and eye damage caused by them.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.